Drug intelligence / Profile preview

diclofenac hydroxyethylpyrrolidine

Development stage
Unknown
Lead developer
Specialized Arab Hospital
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Diclofenac hydroxyethylpyrrolidine is a salt of the non-steroidal anti-inflammatory drug (NSAID) diclofenac. It functions as a potent inhibitor of the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), which are responsible for the production of prostaglandins that mediate pain, fever, and inflammation. In the clinical trial conducted by the Specialized Arab Hospital, this specific formulation was administered via intramuscular injection to evaluate its efficacy in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. By inhibiting the early inflammatory response triggered during the ERCP procedure, the drug aims to reduce the incidence and severity of acute pancreatitis in high-risk patients.

Brand names
AkisFlector
Other names
diclofenac epolamineDHEP
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on diclofenac hydroxyethylpyrrolidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac hydroxyethylpyrrolidine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call